[Federal Register Volume 67, Number 154 (Friday, August 9, 2002)]
[Notices]
[Page 51860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20296]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 00100]


Disease, Disability, and Injury Prevention and Control; Special 
Emphasis Panel: Community Based Strategies To Increase HIV Testing of 
Persons at High Risk in Communities of Color

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Community Based Strategies to Increase 
HIV Testing of Persons At High Risk in Communities of Color, PA# 
00100.
    Times and Dates: 9 a.m.-9:30 a.m., August, 26, 2002 (Open), 9:30 
a.m.-4:30 p.m., August 26, 2002 (Closed), 9 a.m.-4:30 p.m., August 
27-28, 2002 (Closed).
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, GA 30345.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
PA# 00100.
    Contact Person for More Information: Beth Wolfe, Prevention 
Support Office, National Center for HIV, STD, and TB Prevention, 
CDC, 1600 Clifton Road, NE., MS E-07, Atlanta, GA 30333, 404-639-
8025.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Joseph E. Salter,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 02-20296 Filed 8-7-02; 10:52 am]
BILLING CODE 4163-18-P